Cite
HARVARD Citation
Hutchings, K. et al. (2017). Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma. Bioorganic & medicinal chemistry letters. 27 (8), pp. 1744-1749. [Online].